Queensland COVID-19 vaccine begins human trials
The University of Queensland’s promising COVID-19 vaccine begins human trials today.
The vaccine now joins a small group of vaccine developers around the world who are are moving out of the lab and into human trials.
The Queensland vaccine candidate will be trialled in Brisbane at the Nucleus Network clinic at Herston and will involve 120 volunteers out of over 2250 Queenslanders who put up their hands to participate in the Phase 1 trial.
The trial will seek to evaluate the safety and immune response of the vaccine in a group of healthy volunteers.
The UQ research team expects results in about three months.
All going well, the vaccine candidate will then proceed to Phase 2 and 3 clinical trials, with much bigger groups of people across a range of ages.
The announcement of the first volunteer to receive the first jab of the Queensland vaccine coincides with Advance Queensland’s 5th birthday.
The vaccine candidate demonstrates the wisdom of over 20 years of Queensland Government strategic investment in Queensland technology and the innovation economy via Smart State and Advance Queensland.